Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group (Q45757473)

15 December 2017

title

Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group (English)

1 reference

15 December 2017

1 reference

1 reference

1 reference

hepatitis E virus

1 reference

4

Purcell RH

1 reference

15 December 2017

author name string

Mast EE

series ordinal

1

1 reference

15 December 2017

Alter MJ

series ordinal

2

1 reference

15 December 2017

Holland PV

series ordinal

3

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

15 December 2017

published in

Hepatology

1 reference

15 December 2017

volume

27

1 reference

15 December 2017

page(s)

857-861

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Epidemic non-A, non-B hepatitis in Nepal. Recovery of a possible etiologic agent and transmission studies in marmosets.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Enterically transmitted non-A, non-B hepatitis: identification of virus-associated antigen in experimentally infected cynomolgus macaques

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Viral specificity of hepatitis E virus antigens identified by fluorescent antibody assay using recombinant HEV proteins

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Expression of a hepatitis E virus (HEV)-trpE fusion protein containing epitopes recognized by antibodies in sera from human cases and experimentally infected primates

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Serologic identification of hepatitis E virus infections in epidemic and endemic settings

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Enzyme immunoassay for the detection of antibody to hepatitis E virus based on synthetic peptides

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Hepatitis type E in a French population: detection of anti-HEV by a synthetic peptide-based enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Protracted viremia during acute sporadic hepatitis E virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

An Indian strain of hepatitis E virus (HEV): cloning, sequence, and expression of structural region and antibody responses in sera from individuals from an area of high-level HEV endemicity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Hepatitis type E in Italy: a seroepidemiological survey. Study Group of Hepatitis E

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Case report: role of hepatitis E virus in the etiology of community-acquired non-A, non-B hepatitis in Greece

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serological study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Hepatitis E in The Netherlands: imported and endemic

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Determination of hepatitis E virus seroprevalence by using recombinant fusion proteins and synthetic peptides

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Characterization of a prototype strain of hepatitis E virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986–1988) of China

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

A novel virus in swine is closely related to the human hepatitis E virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270331

7 January 2021

Identifiers

DOI

10.1002/HEP.510270331

1 reference

15 December 2017

PubMed ID

9500718

1 reference

15 December 2017